Purple Biotech Ltd (PPBT)

$0.37

+0.01

(+2.3%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $0.36
    $0.39
    $0.37
    downward going graph

    2.7%

    Downside

    Day's Volatility :7.69%

    Upside

    5.13%

    downward going graph
  • $0.30
    $1.80
    $0.37
    downward going graph

    18.3%

    Downside

    52 Weeks Volatility :83.21%

    Upside

    79.44%

    downward going graph

Returns

PeriodPurple Biotech LtdIndex (Russel 2000)
3 Months
-17.73%
0.0%
6 Months
-40.95%
0.0%
1 Year
-68.92%
0.0%
3 Years
-92.31%
-19.4%

Highlights

Market Capitalization
15.0M
Book Value
$1.14
Earnings Per Share (EPS)
-0.79
Wall Street Target Price
8.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-29.07%
Return On Equity TTM
-48.26%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
0.0%
Gross Profit TTM
-120.0K
EBITDA
-21.6M
Diluted Eps TTM
-0.79
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.64
EPS Estimate Next Year
-0.47
EPS Estimate Current Quarter
-0.2
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Analyst Forecast

What analysts predicted

Upside of 2062.16%

Current $0.37
Target $8.00

Technicals Summary

Sell

Neutral

Buy

Purple Biotech Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Purple Biotech Ltd
Purple Biotech Ltd
-23.44%
-40.95%
-68.92%
-92.31%
-91.13%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Purple Biotech Ltd
Purple Biotech Ltd
NA
NA
NA
-0.64
-0.48
-0.29
NA
1.14
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Purple Biotech Ltd
Purple Biotech Ltd
NA
$15.0M
-91.13%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Purple Biotech Ltd

  • Vs NVO

    In the last 1 year, Novo Nordisk A/s has given 59.9% return, outperforming this stock by 128.8%

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 200.6% return, outperforming this stock by 292.9%

Institutional Holdings

  • Armistice Capital, LLC

    8.10%
  • Kingswood Wealth Advisors LLC

    0.71%
  • Morgan Stanley - Brokerage Accounts

    0.52%
  • XTX Topco Ltd

    0.11%
  • Millennium Management LLC

    0.08%
  • Virtu Financial LLC

    0.06%

Company Information

kitov pharmaceuticals ltd. is a financial services company located in israel.

Organization
Purple Biotech Ltd
Employees
20
CEO
Mr. Gil Efron CPA, M.A.
Industry
Miscellaneous

FAQs